Binocular interactions and spatial disparity sensitivity in the superior colliculus of the siamese cat

B. Bacon,F. Lepore,J. Guillemot

DOI: https://doi.org/10.1007/s002210050613

Experimental Brain Research

Abstract:

What problem does this paper attempt to address?

Atrial natriuretic peptide kinetic studies in patients with cardiac dysfunction.

Johannes Hensen,Johannes Hensen,William T. Abraham,William T. Abraham,Edward J. Lesnefsky,Edward J. Lesnefsky,Benny Levenson,Benny Levenson,Bertron M. Groves,Bertron M. Groves,Klaus Schröder,Klaus Schröder,Robert W. Schrier,Robert W. Schrier,Jacques A. Durr

DOI: https://doi.org/10.1038/KI.1992.197

IF: 19.6

1992-05-01

Kidney International

Abstract:
Ketogenic Diet in patients with refractory epilepsy

María J Rebollo G,Ximena Díaz Sm,Marcela Soto R,Johanna Pacheco A,Scarlet Witting E,Isidora Daroch R,Francisco Moraga M

DOI: https://doi.org/10.32641/rchped.vi91i5.1563

Abstract:Introduction: Epilepsy affects 0.5 to 1% of the population. 25% of pediatric patients have drug-resistant epilepsy (DRE). Ketogenic Diet (KD) emerges as an effective, non-pharmacological treatment in this group. Objective: To describe the effect of KD on seizure control and nutritional status in children whit DRE. Patients and method: We reviewed the medical records of patients with DRE treated with KD, between 2008 and 2018, evaluating age, diagnosis, number of seizures, number of antiepileptic drugs used, clinical outcomes, and complications. The KD was initiated in all patients hospitalized for a period no longer than seven days, who were evaluated for their nutritional and anthropometric sta tus, with weight and height measurements according to the clinical condition. Results: We analyzed 35 KD in 33 cases. The median age of KD initiation was 4.8 years with an interquartile range (IQR) of 2-3 to 6.8 years. Classical KD was used in 49% of patients, Modified Atkins Diet (MAD) in 37%, and Low-Glycemic Index Treatment (LGIT) in 14% of cases. The average duration was 13 months (SD 11 months). After three months of using KD, we observed at least 50% reduction of seizures in 82% (27/33) of the patients, out of these, 22.8% presented 90% or more reduction of seizures, and 20% ended up seizure-free. Adverse events were observed in 21 patients, mainly gastrointestinal (62%) and dyslipidemia (14%), without effect on height. All side effects resolved with medical ma nagement. Conclusions: KD is a useful treatment in pediatric patients with DRE without nutritional impact. The adverse events were easily controlled if the patients are evaluated by a multidisciplinary team, according to international guidelines.
Ketogenic diet in patients with Dravet syndrome

Roberto Horacio Caraballo,Ricardo Oscar Cersósimo,Diego Sakr,Araceli Cresta,Nidia Escobal,Natalio Fejerman

DOI: https://doi.org/10.1111/j.1528-1167.2005.05705.x

IF: 6.74

Epilepsia

Abstract:Purpose: The ketogenic diet (KD) has been used as a therapeutic alternative to antiepileptic drugs (AEDs) for refractory epilepsy. Severe myoclonic epilepsy in infants or Dravet syndrome (DS) is one of the most malignant epileptic syndromes. In this retrospective study, we evaluated the efficacy and tolerability of the KD in patients with diagnostic criteria of DS. Methods: Between March 1, 1990, and August 31, 2004, 52 patients who met diagnostic criteria for DS were enrolled in a study at our department. Twenty of them were placed on the KD with the Hopkins protocol and followed up for a minimum of 1 year. Results: Three of the 20 original children stayed on the diet for 12 months, four children for 2 years, four children for 3 years, and two children for 4 years. One year after initiating the diet, 13 (65%) of the initial patients remained on the diet. Two (15%) patients were seizure free, eight (61.7%) children had a 75-99% decrease in seizures, and the remaining three (23%) children had a 50-74% decrease in seizures. Thus 1 year after starting the diet, 10 (77%) children had achieved a >75% decrease in their seizures. Four patients have been off the diet for >2 years; one of them is seizure free, two have sporadic seizures, and one, who abandoned the diet after 2 years of adhering to it, relapsed. No differences in seizure control when compared with age, sex, or seizure type were found. Conclusions: Considering the severity and intractability of seizures in patients with DS, the fact that 10 of the 13 children who remained on the diet had a significant reduction in number of seizures shows that the KD is at present an interesting therapeutic alternative. Even in patients in whom seizure reduction was not dramatic, quality of life improved, and in all of them, the number of AEDs was reduced to one or two. We consider that children with DS should be offered the KD immediately after three adequate trials of AEDs have failed.
The ketogenic diet in patients with myoclonic status in non-progressive encephalopathy

Roberto Caraballo,Francesca Darra,Gabriela Reyes,Marisa Armeno,Araceli Cresta,Graciela Mestre,Bernardo Dalla Bernardina

DOI: https://doi.org/10.1016/j.seizure.2017.07.002

IF: 3.414

Seizure

Abstract:Myoclonic status in non-progressive encephalopathy (MSNPE) is characterized by the recurrence of long-lasting atypical status epilepticus associated with attention impairment and continuous polymorphous jerks, mixed with other complex abnormal movements, in infants suffering from a non-progressive encephalopathy. The ketogenic diet (KD) has been used as an alternative to antiepileptic drugs (AEDs) for patients with refractory epileptic encephalopathies. Purpose: In this study we assess the efficacy and tolerability of the KD in patients with MSNPE. Methods: Between March 1, 1980 and August 31, 2013, 99 patients who met the diagnostic criteria of MSNPE were seen (58 patients in Verona and 41 patients in Buenos Aires). Six of these 99 patients were placed on the KD using the Hopkins protocol and followed for a minimum period of 24 months. Results: Twelve months after initiating the diet, three patients had a 75%-99% decrease in seizures, two had a 50%-74% decrease in seizures, and the remaining child had a less than 50% seizure reduction. In five patients with a seizure reduction of more than 50%, the myoclonic status epilepticus disappeared within 6 months after starting the diet. All patients had very good tolerability and no adverse events were identified. In most of the patients AEDs were reduced. Conclusion: The KD is a promising therapy for MSNPE, with most of our patients showing a more than 50% seizure reduction. In patients that responded well to the diet cognitive performance and quality of life also improved.
Implementation Concerns of Scholar-Practitioners: A Pilot Study of the Link between Research and Practice

Claretha Hughes,Jai Wang,Wei Zheng,L. McLean

DOI: https://doi.org/10.4018/jabim.2010040104

2010-04-01

International Journal of Asian Business and Information Management

Abstract:The challenge of combining research and practice in HRD has led to continuing debate on who are scholar-practitioners and how they integrate research and practice in the workplace. This qualitative collective case study provides insights from seven scholar-practitioners to help HRD professionals and researchers understand implementation concerns of scholar-practitioners. The findings reveal scholar-practitionersâ€™ perceptions of their roles, the link between research and practice, and actions they took to overcome barriers and challenges related to integrating research and practice. This pilot study can serve as a benchmark for future studies regarding successful integration of research and practice in HRD.
Ketogenic Dietary Therapy in Adult Status Epilepticus: Current Progress and Clinical Application

Cai Mengting,Xu Wanyin,Zheng Yang,Ding Meiping

DOI: https://doi.org/10.1186/s42494-022-00082-4

2022-01-01

Acta Epileptologica

Abstract:Status epilepticus (SE) is a common fatal neurological disease with high morbidity and mortality. Even if a large proportion of patients might be relieved from anti-seizure medications, sedatives and anesthetics, some still remain out of control. The ketogenic dietary (KD) has been proven useful in patients refractory to medications and/or who have failed to respond to surgical intervention. Recently, KD has shown beneficial therapeutic effects in children with SE, but studies in adults have rarely been reported. In this paper, we review the efficacy and utility of KD in adult SE patients and highlight its application for clinical reference and management.
Ketogenic Diet in the Treatment of Epilepsy

Kinga Borowicz-Reutt,Marlena Krawczyk,Julia Czernia

DOI: https://doi.org/10.3390/nu16091258

IF: 5.9

2024-04-25

Nutrients

Abstract:Epilepsy is one of the most disabling neurological diseases. Despite proper pharmacotherapy and the availability of 2nd and 3rd generation antiepileptic drugs, deep brain stimulation, and surgery, up to 30–40% of epilepsy patients remain drug-resistant. Consequences of this phenomenon include not only decreased a quality of life, and cognitive, behavioral, and personal disorders, but also an increased risk of death, i.e., in the mechanism of sudden unexpected death in epilepsy patients (SUDEP). The main goals of epilepsy treatment include three basic issues: achieving the best possible seizure control, avoiding the undesired effects of treatment, and maintaining/improving the quality of patients' lives. Therefore, numerous attempts are made to offer alternative treatments for drug-resistant seizures, an example of which is the ketogenic diet. It is a long-known but rarely used dietary therapy for intractable seizures. One of the reasons for this is the unpalatability of the classic ketogenic diet, which reduces patient compliance and adherence rates. However, its antiseizure effects are often considered to be worth the effort. Until recently, the diet was considered the last-resort treatment. Currently, it is believed that a ketogenic diet should be used much earlier in patients with well-defined indications. In correctly qualified patients, seizure activity may be reduced by over 90% or even abolished for long periods after the diet is stopped. A ketogenic diet can be used in all age groups, although most of the available literature addresses pediatric epilepsy. In this article, we focus on the mechanisms of action, effectiveness, and adverse effects of different variants of the ketogenic diet, including its classic version, a medium-chain triglyceride diet, a modified Atkins diet, and a low glycemic index treatment.

nutrition & dietetics
Functional Outcome of Cognitively Impaired Hip Fracture Patients on a Geriatric Rehabilitation Unit

F. Goldstein,D. Strasser,J. Woodard,V. J. Roberts

DOI: https://doi.org/10.1111/j.1532-5415.1997.tb00975.x

1997-01-01

Journal of the American Geriatrics Society

Abstract:OBJECTIVES: To compare outcomes (physical functions and discharge destinations) of cognitively impaired and intact older hip fracture patients, and to identify cognitive skills related to functional gains.
Therapeutic Effects of the Ketogenic Diet in Children with Lennox-Gastaut Syndrome

Yunjian Zhang,Yi Wang,Yuanfeng Zhou,Linmei Zhang,Lifei Yu,Shuizhen Zhou

DOI: https://doi.org/10.1016/j.eplepsyres.2016.11.003

IF: 2.991

2016-01-01

Epilepsy Research

Abstract:Objective: The aim of this study was to evaluate the efficacy of the ketogenic diet (KD) on the clinical and electroencephalographic (EEG) features of Lennox-Gastaut syndrome (LGS) and explore the relationships between EEG changes and clinical efficacy.Methods: We retrospectively studied 47 patients with LGS who accepted KD therapy between May 2011 and May 2015. Clinical efficacy and EEG features such as background activity, abnormal interictal epileptic discharges (IEDs) and the discharge location were evaluated prior to and at 3 and 6 months after therapy. Responders were defined as >= 50% seizure reduction.Results: At 3 months of treatment, 23 patients (48.9%) had >= 50% seizure reduction. Seven patients (14.9%) discontinued treatment between 3 and 6 months because of lack of efficacy or inability to adhere to the diet. At 6 months of treatment, 4 patients (10%) were seizure free, 5 (12.5%) had >= 90% seizure reduction, 12 (30%) had a reduction of 50-89%, and 19 (47.5%) had <50% reduction. Patients with improved EEG background and reduced IEDs had an improved seizure reduction rate compared with patients without change in EEG background or IEDs (p < 0.01).Conclusions: The results show that the KD is effective in LGS. It can control seizures and improve EEG abnormalities. Early improvement in the EEG background and a reduction in IEDs may be predictors of a patient's response to diet. (C) 2016 Elsevier B.V. All rights reserved.
The Ketogenic Diet for Paediatric Patients with Super-Refractory Status Epilepticus in Febrile Infection-Related Epilepsy Syndrome

Wang Xinhua,Gao Xuan,Lu Guoping,Lu Zhongying,Zhou Shuizhen,Wang Yi,Zhou Yuanfeng

DOI: https://doi.org/10.1186/s42494-020-00013-1

2020-01-01

Acta Epileptologica

Abstract:Objective To investigate the effect and safety of ketogenic diet (KD) for the treatment of paediatric patients with super-refractory status epilepticus (SRSE) in febrile infection-related epilepsy syndrome (FIRES). Method From January 1, 2015 to October 31, 2017, ten critically ill paediatric patients with SRSE in FIRES were included in this study and treated with KD. The treatment effects of KD were evaluated by using continuous encephalography (CEEG) and amplitude-integrated electro-encephalography (aEEG). Results All 10 patients fulfilled the diagnostic criteria of SRSE in FIRES and achieved ketosis within 24–72 h following the administration of KD. CEEG and aEEG were monitored for several weeks to assess the efficacy of KD on status epilepticus (SE). SE was contained in 8 patients within 2 to 19 days after initiation of KD, and KD was discontinued in the other 2 patients. One of the 10 patients demonstrated severe adverse effects. Conclusion KD may be an alternative and safe treatment option in critical paediatric patients with SRSE in FIRES.
Chinese expert recommendations on ketogenic diet therapy for super-refractory status epilepticus

Xin Tong,Qianyun Cai,Dezhi Cao,Lifei Yu,Dan Sun,Guang Yang,Jiwen Wang,Hua Li,Zengning Li,Juan Wang,Shaoping Huang,Meiping Ding,Fang Fang,Qun Wang,Rong Luo,Jianxiang Liao,Jiong Qin

DOI: https://doi.org/10.1186/s42494-021-00078-6

2022-01-01

Acta Epileptologica

Abstract:Super-refractory status epilepticus (SRSE) is a serious and life-threatening neurological condition. Ketogenic diet (KD) is a diet characterized by high fat, low carbohydrate, and moderate protein. As KD shows effectiveness in controlling seizures in more than half of SRSE patients, it can be a treatment option for SRSE. Currently, KD treatment for SRSE is based on personal experience and observational evidence has been published. In the context of a lack of a validated guideline, we convened a multicenter expert panel within the China Association Against Epilepsy (CAAE) Ketogenic Diet Commission to work out the Chinese expert recommendations on KD for SRSE. We summarize and discuss the latest clinical practice of KD for SRSE in critical care settings. Recommendations are given on patient selection, the timing of KD, diet implementation, and follow-up. More research data are needed in this area to support better clinical practice.
Short-term effectiveness and side effects of ketogenic diet for drug-resistant epilepsy in children with genetic epilepsy syndromes

Osama Y. Muthaffar,Anas S. Alyazidi,Daad Alsowat,Abdulaziz A. Alasiri,Raidah Albaradie,Lamyaa A. Jad,Husam Kayyali,Mohammed M. S. Jan,Ahmed K. Bamaga,Mohammed A. Alsubaie,Rawan Daghistani,Saleh S. Baeesa,Meshari A. Alaifan,Abdelhakim Makraz,Abrar N. Alsharief,Muhammad Imran Naseer

DOI: https://doi.org/10.3389/fneur.2024.1484752

IF: 3.4

2024-09-18

Frontiers in Neurology

Abstract:Background Drug-resistant epilepsy (DRE) impacts a significant portion, one-third, of individuals diagnosed with epilepsy. In such cases, exploring non-pharmacological interventions are crucial, with the ketogenic diet (KD) standing out as a valuable option. KD, a high-fat and low-carb dietary approach with roots dating back to the 1920s for managing DRE, triggers the formation of ketone bodies and modifies biochemistry to aid in seizure control. Recent studies have increasingly supported the efficacy of KD in addressing DRE, showcasing positive outcomes. Furthermore, while more research is needed, limited data suggests that KD May also be beneficial for specific genetic epilepsy syndromes (GESs). Objective This study aimed to assess the short-term efficacy of KD among pediatric patients diagnosed with GESs. Materials and methods This is a multi-center retrospective analysis of pediatric patients with GESs diagnosed using next-generation sequencing. The enrolled patients followed the keto-clinic protocol, and the KD efficacy was evaluated at 3, 6, and 12-month intervals based on seizure control and compliance. The collection instrument included demographic, baseline, and prognostic data. The collected data was coded and analyzed promptly. Results We enrolled a cohort of 77 patients with a mean current age of 7.94 ± 3.83 years. The mean age of seizure onset was 15.5 months. Notably, patients experienced seizures at a younger age tended to have less positive response to diet. Overall, 55 patients responded favorably to the diet (71.4%) while 22 patients (28.6%) showed no improvement. Patients with genetic etiology showed a significantly more favorable responses to the dietary intervention. Patients with Lennox–Gastaut syndrome showed the most significant improvement (14/15) followed by patients with Dravet syndrome (6/8), and West syndrome (3/4). The number of used anti-seizure medications also played a significant role in determining their response to the diet. While some patients experienced mild adverse events, the most common being constipation, these occurrences were not serious enough to necessitate discontinuation of the diet. Conclusion The study revealed a high improvement rate in seizure control, especially among younger patients and those with later seizure onset. The success of dietary treatment hinges greatly on early intervention and the patient’s age. Certain genetic mutations responded favorably to the KD, while efficacy varied among various genetic profiles.

neurosciences,clinical neurology
The ketogenic diet for super-refractory status epilepticus patients in intensive care units

Eu Gene Park,Jiwon Lee,Jeehun Lee

DOI: https://doi.org/10.1016/j.braindev.2018.12.007

Abstract:Objectives: Super-refractory status epilepticus (SRSE) is one of the most challenging issues in intensive care units (ICUs) in that it is associated with high morbidity and mortality. Although the ketogenic diet (KD) has been reported to be effective in treating of SRSE, the use of the diet as therapy can be complicated by concomitant medical problems specific to critically ill patients. In this study, we aimed to describe our experience of the KD for SRSE patients in ICUs. Methods: We retrospectively reviewed the medical records of 16 patients (10 males, 6 females) with SRSE who were treated with the KD in the ICUs at Samsung Medical Center from July 2005 to July 2017. Results: The median age of seizure onset was 8 years (interquartile range 5-13.5). Prior to diet initiation, the patients were in convulsive or non-convulsive SRSE for a median of 23 days (range, 3-420). The median time to achieve ketosis was 3 days (range, 2-6). The KD was continued for a median of 2.1 months (range, 0.1-15.8). Of the 16 patients, nine (56.3%) achieved seizure freedom, six (37.5%) reported >50% seizure reduction, and one (6.2%) had <50% seizure improvement after the KD. There was no significant change in the number of antiepileptic drugs. The most commonly encountered complication during the KD was gastrointestinal disturbance. Conclusions: Our experience indicates that the KD is an effective alternative therapeutic strategy for SRSE patients in ICUs with adequate efficacy and safety in reducing seizure frequency and weaning from prolonged mechanical ventilation, although functional outcome was not favorable for most patients. Close monitoring and preventive management of potential adverse effects are critical elements for success with the KD in patients with SRSE.
Ketogenic Diets in the Treatment of Epilepsy

Maurizio Elia,Joerg Klepper,Baerbel Leiendecker,Hans Hartmann

DOI: https://doi.org/10.2174/1381612823666170809101517

Abstract:Background: Although a larger number of antiepileptic drugs became available in the last decades, epilepsy remains drug-resistant in approximately a third of patients. Ketogenic diet (KD), first proposed at the beginning of the last century, is complex and has anticonvulsant effects, yet not completely understood. Over the last decades, different types of ketogenic diets (KDs) have been developed, namely classical KD and modified Atkins diet (MAD). They offer an effective alternative for children and adults with drug-resistant epilepsies. Methods: We review several papers on KDs as an adjunctive treatment of refractory epilepsy of children and adults, discussing its efficacy and adverse events. Because of the heterogenous, uncontrolled nature of the studies, we analyzed all studies individually, without a meta-analysis. Results: KDs may be considered first choice treatment in some specific metabolic conditions, such as glucosetransporter type 1 and pyruvate dehydrogenase deficiencies, and mitochondrial complex I defects. Preliminary findings indicate that KDs may be specifically effective in some epileptic syndromes, such as West syndrome, severe myoclonic epilepsy of infancy, myoclonic-astatic epilepsy, febrile infection related epileptic syndrome, and drug-resistant idiopathic generalized epilepsies or refractory status epilepticus. Short term adverse events are usually mild in both children and adults, including gastrointestinal symptoms, hyperlipidemia, and hypercalciuria; potential long term adverse effects include nephrolitiasis, decreased bone density, and liver steatosis. Possible atherosclerotic effects remain a concern. Patients on KDs should be carefully monitored in specialized centers during initiation, maintenance and withdrawal periods, in order to minimize such adverse events, and to improve compliance. Although the majority of KD trials on children and adults with drug-resistant epilepsies are openlabel, uncontrolled studies based on small samples, an increasing number of randomized controlled trials have provided better quality evidence on its efficacy in recent years. Conclusion: There is a need for future randomized clinical trials aimed to confirm the efficacy of KDs in specific epileptic syndromes, and to provide further information about some practical unsolved problems, i.e. for how long KD treatment should be continued.
Therapeutic Success of the Ketogenic Diet As A Treatment Option for Epilepsy: A Meta-Analysis

Hai-feng Li,Yan Zou,Gangqiang Ding

2013-01-01

Iranian Journal of Pediatrics

Abstract:Objective: To systematically evaluate therapeutic success of the ketogenic diet (KD) as a treatment option for epilepsy.Methods: Using MEDLINE and Google Scholar search, we searched for studies investigating the therapeutic success of ketogenic diet for epilepsy. We estimated therapeutic success rate for ketogenic diet as a treatment option for epilepsy and its 95% CIs using generic inverse variance method.Findings: A total of 38 studies met the inclusion criteria. In retrospective studies, the weighted success rate of the patients who take the KD as a treatment option for epilepsy was 58.4% (95% confidence interval (95% CI)=48.7% - 69.9%) at 3 months (n=336); 42.8% (95% CI =36.3% - 50.3%) at 6 months (n=492), and 30.1% (95% CI =24.3% - 37.2%) at 12 months (n=387); in prospective studies, weighted success rate was 53.9% (95% CI 45.5% - 63.8%) at 3 months (n=474); 53.2% (95% CI =44.0% - 64.2%) at 6 months (n=321), and 55.0% (95% CI =45.9% - 65.9%) at 12 months (n=347).Conclusion: This meta-analysis provides formal statistical support for the efficacy of the ketogenic diet in the treatment of epileptic patients.
AXENIC CULTURE OF TETRATRICHOMONAS GALLINARUM: GROWTH AND ANAEROBIC UTILIZATION OF CARBOHYDRATES AND RELATED COMPOUNDS.

V. Theodorides

DOI: https://doi.org/10.1016/0014-4894(64)90034-7

IF: 2.132

1964-10-01

Experimental Parasitology

Abstract:
Prospective Study on Ketogenic Diet on Refractory Epilepsy in Children

JI Xin-na,QIN Jiong,XIONG Hui,BAO Xin-hua,WANG Shuang,ZHANG Yue-hua

2009-01-01

Abstract:Objective To assess the efficacy and safety of ketogenic diet(KD) on refractory epilepsy in children.Methods KD treatment was designed to observe the effects for 12 weeks.Totally 22 children with 16 boys and 6 girls were enrolled in the study.The epileptic syndromes included infantile spasms(13 cases),Lennox-Gastaut syndrome(4 cases),Dravet syndrome(2 cases),and the unclassified(3 cases).The KD was prepared according to the modified Johns Hopkins regimen.Urinary ketones were measured every day to ensure that ketosis state and parents′ diaries were kept to find out when it started to work and the change of seizure frequency.Effects of KD was evaluated by Engel standard.Blood chemistry was done at baseline,4 weeks and 12 weeks to analyze the effects of KD on metabolism.Side effects were monitored and treated.Results All cases completed the KD regimen for at least 2 weeks,19 cases for at least 4 weeks,and 10 cases for at least 12 weeks.Sixteen out of 22 children experienced the seizure reduction within 3 weeks(1-15 d),especially in the first week,and seizure free appeared within 5 weeks(1-32 d) in 8 cases.Overall,the diet achieved the seizure-free in 36.4%(8/22 cases) and an over 90% of seizure frequency reduction in 22.7%(5/22 cases).The efficacy of KD seemed not correlated with the sex,age,etiopathogenisis,and syndromes and so on.Blood chemistry suggested a normal range of glucose level at 4 weeks,though higher than that at the baseline.The blood triglyceride and total cholesterol level at 12 weeks increased strikingly,even beyond the normal range compared with the baseline.The side effects mainly including transient gastrointestinal symptoms and metabolic disturbances were mostly tolerable.Conclusions KD is probably a feasible therapy on refractory epilepsy in children,with quick and high efficacy and few side effects.
Efficacy of a ketogenic diet in resistant myoclono-astatic epilepsy: A French multicenter retrospective study

Elodie Stenger,Mickael Schaeffer,Claude Cances,Jacques Motte,Stéphane Auvin,Dorothée Ville,Hélène Maurey,Rima Nabbout,Anne de Saint-Martin

DOI: https://doi.org/10.1016/j.eplepsyres.2017.02.005

Abstract:Objective: Recent studies have suggested that the early introduction of a ketogenic diet (KD) could improve seizure control in myoclono-astatic epilepsy (MAE). This multicenter study sought to identify the benefits of KD use on seizure control and epilepsy and on developmental outcomes in children with resistant MAE. Methods: Fifty children who were diagnosed with severe MAE in the French network of Reference Centers for Rare Epilepsies and who were treated with KD between 2000 and 2013 were included in this study. The seizure frequency and EEG recordings were assessed two weeks before KD introduction, 2 and 6 months after, and during the last follow-up, which also included an assessment of developmental outcome. Results: Patients had a median follow up of 52 months (range 13-136) and received 4.3 antiepileptic drugs [2-9] before KD introduction. Fifty-four percent (54%) of our patients were seizure-free after 6 months of KD or more, and 86% experienced more than a 70% seizure reduction after 2 months of KD. Forty-four percent (44%) of them had a clear benefit of early KD treatment (after four AEDs failed). Early KD treatment did not result in a greater seizure reduction (p=0.055), but significantly resulted in remission (p<0.028). Fifty percent of patients with resistant MAE had normal development outcomes. Earlier KD treatment, after three AEDs failed, was correlated with a better cognitive outcome (p<0.01). Significance: Early introduction of KD treatment in resistant MAE has a strong, persistent anticonvulsant effect with long-term remission and better cognitive outcomes.
The Efficacy of Ketogenic Diet in 60 Chinese Patients with Dravet Syndrome

Xiaojuan Tian,Jiaoyang Chen,Jing Zhang,Xiaoling Yang,Taoyun Ji,Yao Zhang,Ye Wu,Fang,Xiru Wu,Yuehua Zhang

DOI: https://doi.org/10.3389/fneur.2019.00625

IF: 3.4

2019-01-01

Frontiers in Neurology

Abstract:Objective: To evaluate the efficacy and safety of ketogenic diet (KD) in patients with Dravet syndrome (DS).Methods: 60 DS patients receiving treatment of KD for more than 12 weeks from 2009 to 2018 were analyzed retrospectively. Modified Johns Hopkins protocol was used to initiate KD. Seizure frequency, electroencephalogram (EEG), cognition, language, and motor function of the patients were assessed. Side effects were monitored and adjusted accordingly. SPSS 23.0 software was used for all statistical analysis.Results: In total, 60 DS patients (34 boys, 26 girls) received treatment of KD for more than 12 weeks, and among them 41 (68.3%) patients remained on the diet for more than 24 weeks, 22 (36.7%) patients for more than 48 weeks. Seizures in 35 patients (58.3%) were reduced by over 50% at 12 weeks, and the KD effect was observed within 2 weeks in most of them. At 24 weeks, 61.1% (25/41) of the patients had a >50% seizure reduction. At 48 weeks, 77.3% (17/22) had an over 50% reduction in their seizure frequency. With the treatment of KD in the 60 DS patients, 10 patients had ever been seizure free for 12 months to 24 months (The median duration was 20 months). In 10 KD-effective patients, the background rhythm of their EEG showed obvious improvement, and interictal epileptic discharges decreased significantly. Cognitive function of 22 patients was improved. Language progressed in 14 patients. Motor function was improved in 13 patients. The efficacy of KD in DS patients did not correlate with the seizure onset age, the starting age of KD treatment, the SCN1A mutation and the numbers of antiepileptic drugs combined with KD treatment. The main adverse reactions of KD in the treatment process were gastrointestinal symptoms and metabolic disorders.Conclusions: KD treatment in DS patients has many advantages, including working rapidly, being effective in more than half of the DS patients and tolerable adverse reactions. Pharmoco-resistant DS patients are suggested to receive KD treatment.
Evaluation of the seizure control and the tolerability of ketogenic diet in Chinese children with structural drug-resistant epilepsy

Xiangjun Dou,Xiaoke Xu,Tingting Mo,Hua Chen,Zhijing Wang,Xia Li,Shanshan Jia,Dong Wang

DOI: https://doi.org/10.1016/j.seizure.2021.11.008

IF: 3.414

2022-01-01

Seizure

Abstract:OBJECTIVES: In this study, we aimed to evaluate the efficacy and tolerability of ketogenic diet (KD) in Chinese children with drug-resistant epilepsy (DRE) due to structural etiology.METHODS: We retrospectively analyzed data from 23 pediatric patients with DRE due to structural etiology who were treated with KD at Department of Neurology, between May 2014 and December 2020. Based on etiological classifications, the patients were divided into a neonatal brain injury (Group 1), an intracranial infection group (Group2) and a group that showed malformations of cortical development (MCDs) (Group 3).RESULTS: The 23 patients remained on the KD for a mean duration of 15.3 ± 9.7 months. The response rates for the control of seizures were 60.9% (14/23), 52.2 % (12/23), 47.8% (11/23) at 3, 6 and 12 months, respectively. Subjective improvements in cognition were observed in 87.0% (20/23) of the children during follow-up. Reductions in the frequency of seizures of > 50% were more commonly achieved by patients in group 1 (75.0%, 9/12) compared to the patients in groups 2 (60.0%, 3/5) and 3 (33.4%, 2/6). Further analysis of the patients in Group 1 showed that children with a history of hypoxic ischemic encephalopathy (HIE) (100.0%, 6/6) had the highest rate of > 50% seizure reduction. The main reasons for the discontinuation of the KD were due to lack of efficacy and poor compliance. Most of the side effects associated with the KD diet were minor and easily corrected by appropriately adjusting the diet. Only 1 patient discontinued the diet due to severe refusal to eat.CONCLUSIONS: KD is an effective and safe treatment for Chinese children with DRE due to structural etiology. Better efficacy of seizure control was observed in patients with a history of neonatal brain injury. Patients with DRE secondary to HIE may be particularly responsive to the KD therapy, and so KD should be considered earlier in those patients.

neurosciences,clinical neurology

Binocular interactions and spatial disparity sensitivity in the superior colliculus of the siamese cat

Atrial natriuretic peptide kinetic studies in patients with cardiac dysfunction.

Ketogenic Diet in patients with refractory epilepsy

Ketogenic diet in patients with Dravet syndrome

The ketogenic diet in patients with myoclonic status in non-progressive encephalopathy

Implementation Concerns of Scholar-Practitioners: A Pilot Study of the Link between Research and Practice

Ketogenic Dietary Therapy in Adult Status Epilepticus: Current Progress and Clinical Application

Ketogenic Diet in the Treatment of Epilepsy

Functional Outcome of Cognitively Impaired Hip Fracture Patients on a Geriatric Rehabilitation Unit

Therapeutic Effects of the Ketogenic Diet in Children with Lennox-Gastaut Syndrome

The Ketogenic Diet for Paediatric Patients with Super-Refractory Status Epilepticus in Febrile Infection-Related Epilepsy Syndrome

Chinese expert recommendations on ketogenic diet therapy for super-refractory status epilepticus

Short-term effectiveness and side effects of ketogenic diet for drug-resistant epilepsy in children with genetic epilepsy syndromes

The ketogenic diet for super-refractory status epilepticus patients in intensive care units

Ketogenic Diets in the Treatment of Epilepsy

Therapeutic Success of the Ketogenic Diet As A Treatment Option for Epilepsy: A Meta-Analysis

AXENIC CULTURE OF TETRATRICHOMONAS GALLINARUM: GROWTH AND ANAEROBIC UTILIZATION OF CARBOHYDRATES AND RELATED COMPOUNDS.

Prospective Study on Ketogenic Diet on Refractory Epilepsy in Children

Efficacy of a ketogenic diet in resistant myoclono-astatic epilepsy: A French multicenter retrospective study

The Efficacy of Ketogenic Diet in 60 Chinese Patients with Dravet Syndrome

Evaluation of the seizure control and the tolerability of ketogenic diet in Chinese children with structural drug-resistant epilepsy